C3is (CISS) Competitors $2.64 +0.38 (+16.81%) As of 12:38 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CISS vs. MODV, SGLY, SQZ, OP, GVH, USDP, AIRTP, BLDEW, RA, and HSHPShould you be buying C3is stock or one of its competitors? The main competitors of C3is include ModivCare (MODV), Singularity Future Technology (SGLY), SQZ Biotechnologies (SQZ), OceanPal (OP), Globavend (GVH), USD Partners (USDP), Air T (AIRTP), Blade Air Mobility (BLDEW), Brookfield Real Assets Income Fund (RA), and Himalaya Shipping (HSHP). These companies are all part of the "transportation" industry. C3is vs. Its Competitors ModivCare Singularity Future Technology SQZ Biotechnologies OceanPal Globavend USD Partners Air T Blade Air Mobility Brookfield Real Assets Income Fund Himalaya Shipping C3is (NASDAQ:CISS) and ModivCare (NASDAQ:MODV) are both small-cap transportation companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk. Do institutionals & insiders believe in CISS or MODV? 10.5% of C3is shares are held by institutional investors. 15.5% of ModivCare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is CISS or MODV more profitable? C3is has a net margin of 20.51% compared to ModivCare's net margin of -8.33%. ModivCare's return on equity of 13.64% beat C3is' return on equity.Company Net Margins Return on Equity Return on Assets C3is20.51% 5.41% 4.07% ModivCare -8.33%13.64%-1.19% Do analysts prefer CISS or MODV? ModivCare has a consensus price target of $6.50, indicating a potential upside of 1,373.92%. Given ModivCare's stronger consensus rating and higher possible upside, analysts clearly believe ModivCare is more favorable than C3is.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score C3is 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00ModivCare 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has higher earnings and valuation, CISS or MODV? C3is has higher earnings, but lower revenue than ModivCare. C3is is trading at a lower price-to-earnings ratio than ModivCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioC3is$36.42M0.07-$2.75M-$18.04-0.15ModivCare$2.75B0.00-$201.28M-$16.10-0.03 Does the media refer more to CISS or MODV? In the previous week, C3is had 1 more articles in the media than ModivCare. MarketBeat recorded 1 mentions for C3is and 0 mentions for ModivCare. C3is' average media sentiment score of 1.91 beat ModivCare's score of 0.00 indicating that C3is is being referred to more favorably in the media. Company Overall Sentiment C3is Very Positive ModivCare Neutral Which has more risk & volatility, CISS or MODV? C3is has a beta of 1.7, meaning that its stock price is 70% more volatile than the S&P 500. Comparatively, ModivCare has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500. SummaryC3is and ModivCare tied by winning 8 of the 16 factors compared between the two stocks. Get C3is News Delivered to You Automatically Sign up to receive the latest news and ratings for CISS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CISS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CISS vs. The Competition Export to ExcelMetricC3isTRANS IndustryTransportation SectorNASDAQ ExchangeMarket Cap$2.45M$2.56B$7.18B$10.26BDividend YieldN/A4.65%940.04%4.60%P/E Ratio-0.1511.3317.2526.36Price / Sales0.073.27447.73167.32Price / CashN/A4.627.9829.90Price / Book0.000.882.436.29Net Income-$2.75M$498.97M$556.72M$270.30M7 Day Performance28.78%2.43%5.54%1.95%1 Month Performance-20.00%5.38%7.36%6.14%1 Year Performance-84.83%-9.87%9.49%27.92% C3is Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CISSC3is0.8997 of 5 stars$2.64+16.8%N/A-87.0%$2.45M$36.42M-0.15N/APositive NewsHigh Trading VolumeMODVModivCare3.3233 of 5 stars$0.44-23.6%$8.38+1,799.1%-96.9%$6.33M$2.75B-0.0320,200Gap DownSGLYSingularity Future Technology0.8737 of 5 stars$1.08-1.1%N/A-30.1%$4.58M$3.14M-1.2540Positive NewsSQZSQZ BiotechnologiesN/A$0.03flatN/AN/A$826K$18.16M-0.011,620OPOceanPalN/A$1.19+1.7%N/A-96.8%$360K$25.70M-0.0260Positive NewsShort Interest ↓GVHGlobavend2.9808 of 5 stars$4.30+0.5%$80.00+1,760.5%-96.5%$321K$16.54M0.007Gap DownHigh Trading VolumeUSDPUSD Partners0.0428 of 5 stars$0.01-1.7%N/A-49.7%$193K$72.32M-0.0190Gap UpAIRTPAir TN/A$19.25+0.4%N/A+9.7%$0.00$296.31M0.00500BLDEWBlade Air MobilityN/A$0.18+7.1%N/A-10.5%$0.00$254.34M0.00130Positive NewsGap UpRABrookfield Real Assets Income FundN/A$13.57-0.1%N/A-1.0%$0.00$67.52M-123.32N/AShort Interest ↓HSHPHimalaya ShippingN/A$8.23-0.2%N/A+12.5%$0.00$123.58M58.792Positive NewsDividend IncreaseGap Up Related Companies and Tools Related Companies ModivCare Competitors Singularity Future Technology Competitors SQZ Biotechnologies Competitors OceanPal Competitors Globavend Competitors USD Partners Competitors Air T Competitors Blade Air Mobility Competitors Brookfield Real Assets Income Fund Competitors Himalaya Shipping Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CISS) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored“Godfather of AI’s” dire warningAI pioneer Geoffrey Hinton warns the technology could create massive unemployment and widen inequality, but Po...Porter & Company | SponsoredAmerica’s most terrifying chart?MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored(Please Ignore if Already Rich)Discover how to get access to a weekly livestream with TWO Pro Traders for a full month… And learn their un...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C3is Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share C3is With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CISS Stock Alerts